PD Dr. med. Patricia Hirt-Minkowski
Fachärztin Allgemeine Innere Medizin und Nephrologie (Nierenkrankheiten)
- Fähigkeitsausweise:
Praxislabor (KHM)
- Kernkompetenzen:
Dialyse
- Fachgebiet:
- Nephrologie
- Funktion:
- Belegärztin
- Spital:
- Lindenhofspital
Bremgartenstrasse 117, 3012 Bern
- Telefon:
- +41 31 300 26 90
- Fax:
- +41 31 300 26 99
- E-Mail:
- nrnzntrm-brnhnch
ptrchrt-mnkwskhnch - Praxisadresse:
- Dialyse Bern AG
Bremgartenstrasse 119, 3012 Bern - Webseite:
- nierenzentrum.ch
- vCard:
- Zu Kontakten hinzufügen
Lebenslauf
Klinische Schwerpunkte
Innere Medizin und Nephrologie
Aus- und Weiterbildung
1994 – 2000 | Studium Humanmedizin, Universität Zürich |
2001 | Dissertation zur Erlangung des Doktortitels für Humanmedizin |
2007 | FMH Innere Medizin |
2010 | FMH Nephrologie |
Beruflicher Werdegang
2001 | Assistenzärztin Chirurgie, Klinik Sonnenhof Bern |
2002 – 2003 | Assistenzärztin Innere Medizin, Regionalspital Burgdorf |
2004 | Stv. Oberärztin Nephrologie, Regionalspital Burgdorf |
2004 | Assistenzärztin, Kardiologiepraxis Dres. C. A. Chételat und A. Hagmann, Bern |
2005 – 2006 | Assistenzärztin Innere Medizin, Spital Bern Tiefenau |
2006 – 2007 | Assistenzärztin Nephrologie, Kantonsspital Aarau |
2007 | Oberärztin Nephrologie, Innere Medizin, Regionalspital Burgdorf |
2007 – 2010 | Ausbildungsstelle zur Fachärztin Nephrologie, Universitätsspital Basel |
2010 – 2011 | Oberärztin Nephrologie, Innere Medizin, Regionalspital Burgdorf |
2010 | Wissenschaftliche Oberärztin Nephrologie, Universitätsspital Basel |
2011 | Belegärtzin Innere Medizin/Nephrologie Lindenhofspital |
Sprachen
- Muttersprache Deutsch
- Sehr gute Sprachkenntnisse in Wort und Schrift Englisch
- Gute Sprachkenntnisse in Wort und Schrift Französisch
- Gute Sprachkenntnisse in Wort Italienisch
Mitgliedschaften
SGIM
VSAO
SGN
ERA-EDTA
Publikationen
Original
articles (peer reviewed)
2014 | P. Hirt-Minkowski, J. Ho, G. Ang, P. Amico, J. Steiger, , P. Nickerson, S. Schaub Urinary CXCL10 chemokine predicts long-term outcome after renal transplantation; in preparation |
2014 | P. Hirt-Minkowski*, J. Ho*, G. Ang, P. Amico, H. Hopfer, J. Steiger, D. Rush, P. Nickerson, S. Schaub Compartmentalization and confounders of CXCL10 chemokine as a biomarker for subclinical allograft inflammation; in preparation . *contributed equally |
2013 | P. Hirt-Minkowski, H.-P. Marti, G. Hönger, D. Grandgirard, S. L. Leib, P. Amico, S. Schaub Correlation of serum and urinary matrix metalloproteases/tissue inhibitors of metalloproteases with subclinical allograft fibrosis in renal transplantation. Transplant Immunology 2014; 30: 1-6; Epub 2013 Nov 27 |
2013 | L. Scholl, M. Dickenmann, P. Hirt-Minkowski Outcome of dialysis patients aged seventy years or above - A retrospective analysis. Swiss Med Wkly, accepted for publication 2013 Dec 19 |
2013 | S. Schaub, P. Hirt-Minkowski Urinary-cell mRNA and acute kidney-transplant rejection. NEJM 2013; 369: 1858 |
2013 | C. Praehauser*, P. Hirt-Minkowski*, K.S. Bakar, P. Amico, E. Vogler, S. Schaub, M. Mayr Risk factors and outcome of expanded-criteria donor kidney transplants in patients with low immunological risk. Swiss Med Wkly 2013; 143:w13883 *contributed equally |
2012 | P. Hirt-Minkowski, M. Roth, G. Hönger, P. Amico, H. Hopfer, S. Schaub Souble CD30 correlates with clinical, but not subclinical renal allograft rejection. Transplant Int 2013; 26: 75-83; Epub 2012 Nov 8 |
2012 | P. Hirt-Minkowski, P. Amico, J. Ho, G. Ang, H. Hopfer, J. Steiger, D. Rush, P. Nickerson, S. Schaub Detection of clinical and subclinical tubulo-interstitial inflammation by the urinary CXCL10 chemokine in a real-life setting. AJT 2012; 12:1811-1823 |
2012 | P. Hirt-Minkowski, P. Amico, G. Hönger, C. Praehauser, J. Steiger, M. Koller, L. Gürke, M. Mayr, S. Schaub Delayed graft function is not associated with an increased incidence of renal allograft rejection. Clinical Transplantation; 26:E634-633 |
2011 | P. Amico, P. Hirt-Minkowski, G. Hönger, L. Gürke, M.J. Mihatsch, J. Steiger, H. Hopfer, S. Schaub Risk stratification by the virtual crossmatch: a prospective study in 233 renal transplantations. Transplant Int 2011; 24:560–569 |
2008 | A. Bock, P. Hirt-Minkowski, M. Brünisholz, G. Keusch, S. Rey, B. von Albertini for the Swiss EFIXNES trial investigators Darbepoetin alpha in lower-than-equimolar doses maintains haemoglobin levels in stable haemodialysis patients converting from Epoetin alpha/beta. Nephrol Dial Transplant 2008; 23:301-308 |
2001 | P. Minkowski, H. Staege, P. Groscurth, A. Schaffner Effects of trimethoprim and co-trimoxazole on the morphology of Listeria monocytogenes in culture medium and after phagocytosis. Journal of Antimicrobial Chemotherapy 2001; 48:185-193 |
Review articles (peer reviewed)
2013 | P. Hirt-Minkowski, F. Burkhalter, M. Dickenmann Proteinurie – Bedeutung und diagnostisches Vorgehen. Therapeutische Umschau 2013; 70: 269-303 |
2010 | P. Hirt-Minkowski, M. Dickenmann, J.A. Schifferli. Atypical Hemolytic Uremic Syndrome: Update on the Complement System and What Is New. Nephron Clinical Practice 2010; 114:c219-c235 |
Case reports (peer reviewed)
2012 | P. Hirt-Minkowski, Marten Trendelenburg, Isabel Gröschl, Andreas Fischer, Ingmar Heijnen, Jürg A. Schifferli A trial of complement inhibition in a patient with cryoglobulin-induced glomerulonephritis. Case Reports in Nephrology and Urology 2012; published online |
2011 | R. Hochuli, A. Stoller, M. Egger, R. Escher, M. Klein Lüthi, P. Hirt-Minkowski. Akute Poststreptokokken-Glomerulonephritis – selten, aber wichtig genug, nicht vergessen zu werden! Schweiz Med Forum 2011; 11:816-819 |
2011 | B. Hess, A. Hugi, R. Escher, M. Klein Lüthi, P. Hirt-Minkowski Schweres Allopurinol-Hypersensitivitätssyndrom – Eine vermeidbare Medikamentennebenwirkung? Schweiz Med Forum 2011; 11: 220–222 |
2009 | P. Hirt-Minkowski, S. Schaub, M. Mayr, J.A. Schifferli, M. Dickenmann, V. Frémeaux-Bacchi and J .Steiger. Haemolytic uraemic syndrome caused by factor H mutation: is single kidney transplantation under intensive plasmatherapy an option? Nephrology Dialysis Transplantation 2009; 24:3548-3551 |